Procedure
retroperitoneal lymph node dissection
retroperitoneal lymph node dissection is a medical procedure with 3 clinical trials. Currently 3 active trials ongoing.
Total Trials
3
Max Phase
—
Type
PROCEDURE
Molecule
—
Success Metrics
Active Trials
3(100%)
Phase Distribution
Ph phase_2
1
33%
Ph not_applicable
1
33%
Phase Distribution
0
Early Stage
1
Mid Stage
0
Late Stage
Phase Distribution2 total trials
Phase 2Efficacy & side effects
1(50.0%)
N/ANon-phased studies
1(50.0%)
Highest Phase Reached
Phase 2Trial Status & Enrollment
Completion Rate
0.0%
0 of 0 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
3
trials recruiting
Total Trials
3
all time
Status Distribution
Active(3)
Detailed Status
Recruiting2
Active, not recruiting1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
3
Success Rate
N/A
Most Advanced
Phase 2
Trials by Phase
Phase 21 (50.0%)
N/A1 (50.0%)
Trials by Status
active_not_recruiting133%
recruiting267%
Recent Activity
3 active trials
Showing 3 of 3
recruiting
THERApy De-escalation for TESTicular Cancer
NCT06309745
active_not_recruitingnot_applicable
Retroperitoneal Lymph Node Dissection in Treating Patients With Testicular Seminoma
NCT02537548
recruitingphase_2
A Clinical Trial of Primary Retroperitoneal Lymph Node Dissection in Patients With Testicular Seminoma With Limited Retroperitoneal Metastases
NCT06932458
Clinical Trials (3)
Showing 3 of 3 trials
NCT06309745
THERApy De-escalation for TESTicular Cancer
NCT02537548Not Applicable
Retroperitoneal Lymph Node Dissection in Treating Patients With Testicular Seminoma
NCT06932458Phase 2
A Clinical Trial of Primary Retroperitoneal Lymph Node Dissection in Patients With Testicular Seminoma With Limited Retroperitoneal Metastases
All 3 trials loaded
Drug Details
- Intervention Type
- PROCEDURE
- Total Trials
- 3